BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.13 Cr | ₹-1.27 Cr | ₹1.62 Cr | ₹19 Cr | ₹-3.82 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BLISS GVS PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.13 Cr |
| Mar2024 | ₹-1.27 Cr |
| Mar2023 | ₹1.62 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹-3.82 Cr |
How is Net Cash Inflow / Outflow of BLISS GVS PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.13 Cr | Positive | |
| Mar2024 | ₹-1.27 Cr | Negative | |
| Mar2023 | ₹1.62 Cr | -91.35 | |
| Mar2022 | ₹19 Cr | Positive | |
| Mar2021 | ₹-3.82 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹3,056.0 Cr | 3% | 8.2% | 145.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,032.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,759.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,224.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹116,214.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,739.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 3% |
8.2% |
145.2% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses